Genscript Biotech Corporation
Latest round
- Series A
Last raised
- Apr 2009
Total raised
- $15M
Investors
- 2
About Genscript Biotech Corporation
Established in 2002 and headquartered in Nanjing, China, Genscript Biotech Corporation is a biotech enterprise that engages in drug development and cell therapy. In 2015, the company was listed in the Hong Kong Exchange Stock. Its stock code is 1548. In 2017, it acquired CustomArray. In 2019, the company established the European Regional Department and the Asia Pacific Regional Department. In 2022, Genscript Biotech Corporation established a production and R&D base in Singapore. The company main operates four platforms include CRO (Contracted Research Organization) platform, CDMO (Contract Development and Manufacturing Organization) platform, industrial synthetic products platform and cell therapy platform. The CRO platform and CDMO platform provides drug development and production services. The industrial synthetic products platform develops products for food and feed processing. The cell therapy platform provides cell therapy solutions for patients with refractory diseases including cancer and inflammatory diseases. In the future, the company will develop and expand production facilities.
Who invested in Genscript Biotech Corporation
2 investors across 1 round
See all investors in Genscript Biotech Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 15, 2009
Amount
$15M
Investors
Questions about Genscript Biotech Corporation
Who invested in Genscript Biotech Corporation?
Genscript Biotech Corporation has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genscript Biotech Corporation raised?
Genscript Biotech Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Genscript Biotech Corporation last raise money?
Genscript Biotech Corporation's most recent round on record is a Series A, in Apr 2009.
What does Genscript Biotech Corporation do?
Established in 2002 and headquartered in Nanjing, China, Genscript Biotech Corporation is a biotech enterprise that engages in drug development and cell therapy.
Where is Genscript Biotech Corporation headquartered?
Genscript Biotech Corporation is headquartered in Nanjing, China.
Which VCs invest in companies like Genscript Biotech Corporation?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Genscript Biotech Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Genscript Biotech Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.